BeOne Medicines (ONC) Profit After Tax: 2015-2025
Historic Profit After Tax for BeOne Medicines (ONC) over the last 11 years, with Sep 2025 value amounting to $124.8 million.
- BeOne Medicines' Profit After Tax rose 202.88% to $124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.5 million, marking a year-over-year increase of 107.97%. This contributed to the annual value of -$644.8 million for FY2024, which is 26.87% up from last year.
- Per BeOne Medicines' latest filing, its Profit After Tax stood at $124.8 million for Q3 2025, which was up 32.36% from $94.3 million recorded in Q2 2025.
- Over the past 5 years, BeOne Medicines' Profit After Tax peaked at $215.4 million during Q3 2023, and registered a low of -$590.7 million during Q4 2021.
- For the 3-year period, BeOne Medicines' Profit After Tax averaged around -$118.7 million, with its median value being -$121.3 million (2024).
- Per our database at Business Quant, BeOne Medicines' Profit After Tax tumbled by 754.48% in 2022 and then skyrocketed by 202.88% in 2025.
- Over the past 5 years, BeOne Medicines' Profit After Tax (Quarterly) stood at -$590.7 million in 2021, then climbed by 24.61% to -$445.3 million in 2022, then climbed by 17.47% to -$367.6 million in 2023, then surged by 58.68% to -$151.9 million in 2024, then spiked by 202.88% to $124.8 million in 2025.
- Its Profit After Tax was $124.8 million in Q3 2025, compared to $94.3 million in Q2 2025 and $1.3 million in Q1 2025.